Regulations.gov document
NDI 1189 - Reinstatement response letter from FDA HFP to NDI 1189 - Reju-Me from Willy…
Other · FDA-2021-S-0023 · posted Dec 9, 2025
Key facts
| Document ID | FDA-2021-S-0023-0109 |
|---|---|
| Title | NDI 1189 - Reinstatement response letter from FDA HFP to NDI 1189 - Reju-Me from Willy Chemicals Inc |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2021-S-0023 |
| Posted | Dec 9, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: